Brannagan, T H <br/><br/>
Early data on long-term efficacy and safety of inotersen in patients with hereditary transthyretin amyloidosis: a 2-year update from the open-label extension of the NEURO-TTR trial.  [electronic resource] 

 -  European journal of neurology  08 2020 
 - 1374-1381 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-1331 
<br/><br/><label>Standard No.: </label>10.1111/ene.14285  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amyloid Neuropathies, Familial--drug therapy<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Oligonucleotides<br/>Prealbumin<br/>Quality of Life